Fibrosing organising pneumonia

Journal of Clinical Pathology

Volumn 66, Issue 10, 2013, Pages 875-881

  Beardsley, Brooke ^a   Rassl, Doris ^b  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; AZITHROMYCIN; CLARITHROMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ERYTHROMYCIN; TETRACYCLINE; TRIAMCINOLONE;

ADJUVANT THERAPY; ALLERGIC PNEUMONITIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; GRANULATION TISSUE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG FUNCTION TEST; LUNG INJURY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; TREATMENT OUTCOME;

FIBROSIS; INFLAMMATION; LUNG;

ADRENAL CORTEX HORMONES; CRYPTOGENIC ORGANIZING PNEUMONIA; FIBROSIS; HUMANS; LUNG;

EID: 84884975993     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201342     Document Type: Review

References (61)

1. Epler GR, Colby TV, McLoud TC. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312:152-8. (Pubitemid 15192862)
2. Popper HH. Bronchiolitis obliterans. Organizing pneumonia. Verh Dtsch Ges Pathol 2002.;86:101-6.
3. Colby TV. Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 1992;102(1 Suppl):38S-43S.
4. Camus P, Lombard JN, Perrichon M, et al. Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone. Thorax 1989;44:711-15. (Pubitemid 19243267)
5. Santrach PJ, Askin FB, Wells RJ, et al. Nodular form of bleomycin-related pulmonary injury in patients with osteogenic sarcoma. Cancer 1989;64:806-11. (Pubitemid 19188816)
6. Crestani B, Valeyre D, Roden S, et al. Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P). Am J Respir Crit Care Med 1998;158:1929-35.
7. Kaufman J, Komorowski R. Bronchiolitis obliterans. A new clinical-pathologic complication of irradiation pneumonitis. Chest 1990;97:1243-4. (Pubitemid 20166825)
8. Epler GR, Colby TV. The spectrum of bronchiolitis obliterans. Chest 1983;83:161-2. (Pubitemid 13185676)
9. Vasu TS, Cavallazzi R, Hirani A, et al. Clinical and radiologic distinctions between secondary bronchiolitis obliterans organizing pneumonia and cryptogenic organizing pneumonia. Respir Care 2009;54:1028-32.
10. Katzenstein AL, Myers JL, Prophet WD, et al. Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol 1986.;10:373-81. (Pubitemid 16066439)
11. Cazzato S, Zompatori M, Baruzzi G, et al. Bronchiolitis obliterans-organizing pneumonia: an Italian experience. Respir Med 2000;94:702-8. (Pubitemid 30458795)
12. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001.;161:158-64. (Pubitemid 32102383)
13. Alasaly K, Muller N, Ostrow DN, et al. Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine (Baltimore) 1995;74:201-11.
14. Chaparro C, Chamberlain D, Maurer J, et al. Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients. Chest 1996;110:1150-4.
15. Yamamoto M, Ina Y, Kitaichi M, et al. Clinical features of BOOP in Japan. Chest 1992.;102(1 Suppl):21S-5S.
16. Yoo JW, Song JW, Jang SJ, et al. Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia. Rheumatology (Oxford) 2011;50:932-8.
17. Tazelaar HD, Viggiano RW, Pickersgill J, et al. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727-33. (Pubitemid 20109165)
18. Bouchardy LM, Kuhlman JE, Ball WC, et al. CT findings in bronchiolitis obliterans organizing pneumonia (BOOP) with radiographic, clinical, and histologic correlation. J Comput Assist Tomogr 1993;17:352-7. (Pubitemid 23151675)
19. Cohen AJ, King TE, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 1994;149:1670-5. (Pubitemid 24175993)
20. Uner AH, Rozum-Slota B, Katzenstein AL. Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener's granulomatosis. A clinicopathologic study of 16 cases. Am J Surg Pathol 1996;20:794-801. (Pubitemid 26230742)
21. Society AT, Society ER. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001. and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002.;165:277-304.
22. Cordier JF, Loire R, Brune J. Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients. Chest 1989;96:999-1004. (Pubitemid 19266547)
23. King TE, Mortenson RL. Cryptogenic organizing pneumonitis. The North American experience. Chest 1992;102(1 Suppl):8S-13S.
24. Costabel U, Teschler H, Schoenfeld B, et al. BOOP in Europe. Chest 1992;102(1 Suppl):14S-20S.
25. Izumi T, Kitaichi M, Nishimura K, et al. Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest 1992;102:715-19.
26. Lohr RH, Boland BJ, Douglas WW, et al. Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med 1997.;157:1323-9. (Pubitemid 27264273)
27. Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, et al. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest 2011;139:893-900.
28. Inoue T, Toyoshima K, Kikui M. Idiopathic bronchiolitis obliterans organizing pneumonia (idiopathic BOOP) in childhood. Pediatr Pulmonol 1996;22:67-72. (Pubitemid 26271375)
29. Kobayashi I, Yamada M, Takahashi Y, et al. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A. Rheumatology (Oxford) 2003;42:371-4. (Pubitemid 36305628)
30. Oymak FS, Demirba̧d HM, Mavili E, et al. Bronchiolitis obliterans organizing pneumonia. Clinical and roentgenological features in 26 cases. Respiration 2005;72:254-62. (Pubitemid 40981084)
31. Lazor R, Vandevenne A, Pelletier A, et al. Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P). Am J Respir Crit Care Med 2000;162(2 Pt 1):571-7. (Pubitemid 30647202)
32. Yousem SA, Lohr RH, Colby TV. Idiopathic bronchiolitis obliterans organizing pneumonia/cryptogenic organizing pneumonia with unfavorable outcome: pathologic predictors. Mod Pathol 1997;10:864-71. (Pubitemid 27431959)
33. Nagai S, Aung H, Tanaka S, et al. Bronchoalveolar lavage cell findings in patients with BOOP and related diseases. Chest 1992;102(1 Suppl):32S-7S.
34. Boots RJ, McEvoy JD, Mowat P, et al. Bronchiolitis obliterans organising pneumonia: a clinical and radiological review. Aust N Z J Med 1995;25:140-5.
35. Yoshinouchi T, Ohtsuki Y, Kubo K, et al. Clinicopathological study on two types of cryptogenic organizing pneumonitis. Respir Med 1995;89:271-8.
36. Argiriadi PA, Mendelson DS. High resolution computed tomography in idiopathic interstitial pneumonias. Mt Sinai J Med 2009;76:37-52.
37. Domingo JA, Pérez-Calvo JI, Carretero JA, et al. Bronchiolitis obliterans organizing pneumonia. An unusual cause of solitary pulmonary nodule. Chest 1993;103:1621-3.
38. Lee JW, Lee KS, Lee HY, et al. Cryptogenic organizing pneumonia: serial highresolution CT findings in 22 patients. AJR Am J Roentgenol 2010;195:916-22.
39. Watanabe K, Senju S, Wen FQ, et al. Factors related to the relapse of bronchiolitis obliterans organizing pneumonia. Chest 1998;114:1599-606. (Pubitemid 128487482)
40. Maldonado F, Daniels CE, Hoffman EA, et al. Focal organizing pneumonia on surgical lung biopsy: causes, clinicoradiologic features, and outcomes. Chest 2007.;132:1579-83. (Pubitemid 350161585)
41. Iannuzzi MC, Farhi DC, Bostrom PD, et al. Fulminant respiratory failure and death in a patient with idiopathic bronchiolitis obliterans. Arch Intern Med 1985;145:733-4. (Pubitemid 15077945)
42. Schlesinger C, Koss MN. The organizing pneumonias : a critical review of current concepts and treatment. Treat Respir Med 2006;5:193-206.
43. Jaehee L, Ick CS, In PT, et al. Adjunctive effects of cyclosporine and macrolide in rapidly progressive cryptogenic organizing pneumonia with no prompt response to steroid. Intern Med 2010;50:475-9.
44. Lee JS, Lynch DA, Sharma S, et al. Organizing pneumonia: prognostic implication of high-resolution computed tomography features. J Comput Assist Tomogr 2003;27:260-5. (Pubitemid 37047228)
45. Nizami IY, Kissner DG, Visscher DW, et al. Idiopathic bronchiolitis obliterans with organizing pneumonia. An acute and life-threatening syndrome. Chest 1995.;108:271-7.
46. Cordier JF. Cryptogenic organising pneumonia. Eur Respir J 2006;28:422-46.
47. Ranzani OT, Parra ER, de Morais Fernezlian S, et al. Intraluminal plugs in idiopathic and secondary organizing pneumonia: repair or remodelling? Histopathology 2007.;51:622-30. (Pubitemid 47572871)
48. Selman M, King TE, Pardo A, et al. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-51. (Pubitemid 32096342)
49. Adamson IY, Young L, Bowden DH. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 1988;130:377-83. (Pubitemid 18076372)
50. Lappi-Blanco E, Kaarteenaho-Wiik R, Salo S, et al. Laminin-5 gamma2 chain in cryptogenic organizing pneumonia and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004;169:27-33. (Pubitemid 38233885)
51. Selman M, Ruiz V, Cabrera S, et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 2000;279:L562-74.
52. Selman M, Pardo A. Idiopathic pulmonary fibrosis: an epithelial/ fibroblastic cross-talk disorder. Respir Res 2002;3:3.
53. Uhal BD, Joshi I, Hughes WF, et al. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 1998;275 (6 Pt 1):L1192-9.
54. Lappi-Blanco E, Soini Y, Pääkkö P. Apoptotic activity is increased in the newly formed fibromyxoid connective tissue in bronchiolitis obliterans organizing pneumonia. Lung 1999;177:367-76.
55. Lappi-Blanco E, Kaarteenaho-Wiik R, Soini Y, et al. Intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia are highly capillarized. Hum Pathol 1999.;30:1192-6. (Pubitemid 29480887)
56. Lappi-Blanco E, Soini Y, Kinnula V, et al. VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia. J Pathol 2002;196:220-7. (Pubitemid 34110904)
57. Selman M, Pardo A. The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2003;29(3 Suppl): S93-7. (Pubitemid 37070317)
58. Chilosi M, Poletti V, Zamò A, et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003;162:1495-502. (Pubitemid 36512831)
59. Willis BC, Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007;293:L525-34. (Pubitemid 47358808)
60. El-Zammar O, Rosenbaum P, Katzenstein AL. Proliferative activity in fibrosing lung diseases: a comparative study of Ki-67 immunoreactivity in diffuse alveolar damage, bronchiolitis obliterans-organizing pneumonia, and usual interstitial pneumonia. Hum Pathol 2009;40:1182-8.
61. Fukuda Y, Ishizaki M, Kudoh S, et al. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 1998;78:687-98. (Pubitemid 28307326)